vs

Side-by-side financial comparison of CLARIVATE PLC (CLVT) and Spectrum Brands Holdings, Inc. (SPB). Click either name above to swap in a different company.

Spectrum Brands Holdings, Inc. is the larger business by last-quarter revenue ($677.0M vs $585.5M, roughly 1.2× CLARIVATE PLC). Spectrum Brands Holdings, Inc. runs the higher net margin — 4.2% vs -6.9%, a 11.1% gap on every dollar of revenue. On growth, CLARIVATE PLC posted the faster year-over-year revenue change (-1.4% vs -3.3%). CLARIVATE PLC produced more free cash flow last quarter ($78.9M vs $59.3M). Over the past eight quarters, Spectrum Brands Holdings, Inc.'s revenue compounded faster (-2.9% CAGR vs -5.1%).

Clarivate Plc is a British-American publicly traded analytics company that operates a collection of subscription-based services, in the areas of bibliometrics and scientometrics; business and market intelligence, and competitive profiling for pharmacy and biotech, patents, and regulatory compliance; trademark protection, and domain and brand protection. Clarivate calculates the impact factor of scientific journals, using data from its Web of Science product family, that also includes services...

Spectrum Brands Holdings, Inc. is an American multinational consumer products conglomerate headquartered in Middleton, Wisconsin. It was established in 2005 as the successor to Rayovac Corporation.

CLVT vs SPB — Head-to-Head

Bigger by revenue
SPB
SPB
1.2× larger
SPB
$677.0M
$585.5M
CLVT
Growing faster (revenue YoY)
CLVT
CLVT
+1.9% gap
CLVT
-1.4%
-3.3%
SPB
Higher net margin
SPB
SPB
11.1% more per $
SPB
4.2%
-6.9%
CLVT
More free cash flow
CLVT
CLVT
$19.6M more FCF
CLVT
$78.9M
$59.3M
SPB
Faster 2-yr revenue CAGR
SPB
SPB
Annualised
SPB
-2.9%
-5.1%
CLVT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CLVT
CLVT
SPB
SPB
Revenue
$585.5M
$677.0M
Net Profit
$-40.2M
$28.4M
Gross Margin
67.2%
35.7%
Operating Margin
4.0%
Net Margin
-6.9%
4.2%
Revenue YoY
-1.4%
-3.3%
Net Profit YoY
-163.1%
20.9%
EPS (diluted)
$-0.06
$1.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLVT
CLVT
SPB
SPB
Q1 26
$585.5M
Q4 25
$617.0M
$677.0M
Q3 25
$623.1M
$733.5M
Q2 25
$621.4M
$699.6M
Q1 25
$593.7M
$675.7M
Q4 24
$663.0M
$700.2M
Q3 24
$622.2M
$773.8M
Q2 24
$650.3M
$779.4M
Net Profit
CLVT
CLVT
SPB
SPB
Q1 26
$-40.2M
Q4 25
$3.1M
$28.4M
Q3 25
$-28.3M
$55.6M
Q2 25
$-72.0M
$19.9M
Q1 25
$-103.9M
$900.0K
Q4 24
$-191.8M
$23.5M
Q3 24
$-65.6M
$28.5M
Q2 24
$-304.3M
$6.1M
Gross Margin
CLVT
CLVT
SPB
SPB
Q1 26
67.2%
Q4 25
66.8%
35.7%
Q3 25
65.0%
35.0%
Q2 25
67.2%
37.8%
Q1 25
65.1%
37.5%
Q4 24
65.7%
36.8%
Q3 24
66.2%
37.2%
Q2 24
67.2%
38.9%
Operating Margin
CLVT
CLVT
SPB
SPB
Q1 26
Q4 25
6.7%
4.0%
Q3 25
7.1%
4.0%
Q2 25
1.1%
4.5%
Q1 25
-3.5%
2.9%
Q4 24
-9.4%
6.4%
Q3 24
3.5%
2.8%
Q2 24
-36.9%
6.1%
Net Margin
CLVT
CLVT
SPB
SPB
Q1 26
-6.9%
Q4 25
0.5%
4.2%
Q3 25
-4.5%
7.6%
Q2 25
-11.6%
2.8%
Q1 25
-17.5%
0.1%
Q4 24
-28.9%
3.4%
Q3 24
-10.5%
3.7%
Q2 24
-46.8%
0.8%
EPS (diluted)
CLVT
CLVT
SPB
SPB
Q1 26
$-0.06
Q4 25
$0.00
$1.21
Q3 25
$-0.04
$2.19
Q2 25
$-0.11
$0.80
Q1 25
$-0.15
$0.03
Q4 24
$-0.27
$0.84
Q3 24
$-0.09
$1.03
Q2 24
$-0.46
$0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLVT
CLVT
SPB
SPB
Cash + ST InvestmentsLiquidity on hand
$126.6M
Total DebtLower is stronger
$4.3B
Stockholders' EquityBook value
$4.8B
$1.9B
Total Assets
$10.9B
$3.4B
Debt / EquityLower = less leverage
0.89×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLVT
CLVT
SPB
SPB
Q1 26
Q4 25
$329.2M
$126.6M
Q3 25
$318.7M
$123.6M
Q2 25
$362.6M
$122.0M
Q1 25
$354.0M
$96.0M
Q4 24
$295.2M
$179.9M
Q3 24
$388.5M
$368.9M
Q2 24
$376.4M
$306.8M
Total Debt
CLVT
CLVT
SPB
SPB
Q1 26
$4.3B
Q4 25
$4.3B
Q3 25
$4.4B
$496.1M
Q2 25
$4.5B
Q1 25
$4.5B
Q4 24
$4.5B
Q3 24
$4.6B
$496.1M
Q2 24
$4.6B
Stockholders' Equity
CLVT
CLVT
SPB
SPB
Q1 26
$4.8B
Q4 25
$4.8B
$1.9B
Q3 25
$4.9B
$1.9B
Q2 25
$5.0B
$1.9B
Q1 25
$5.0B
$1.9B
Q4 24
$5.1B
$2.0B
Q3 24
$5.5B
$2.1B
Q2 24
$5.6B
$2.1B
Total Assets
CLVT
CLVT
SPB
SPB
Q1 26
$10.9B
Q4 25
$11.1B
$3.4B
Q3 25
$11.2B
$3.4B
Q2 25
$11.4B
$3.5B
Q1 25
$11.5B
$3.5B
Q4 24
$11.5B
$3.6B
Q3 24
$12.0B
$3.8B
Q2 24
$12.1B
$3.8B
Debt / Equity
CLVT
CLVT
SPB
SPB
Q1 26
0.89×
Q4 25
0.89×
Q3 25
0.90×
0.26×
Q2 25
0.90×
Q1 25
0.90×
Q4 24
0.88×
Q3 24
0.84×
0.23×
Q2 24
0.83×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLVT
CLVT
SPB
SPB
Operating Cash FlowLast quarter
$134.7M
$67.4M
Free Cash FlowOCF − Capex
$78.9M
$59.3M
FCF MarginFCF / Revenue
13.5%
8.8%
Capex IntensityCapex / Revenue
9.5%
1.2%
Cash ConversionOCF / Net Profit
2.37×
TTM Free Cash FlowTrailing 4 quarters
$333.9M
$302.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLVT
CLVT
SPB
SPB
Q1 26
$134.7M
Q4 25
$159.9M
$67.4M
Q3 25
$181.1M
$171.1M
Q2 25
$116.3M
$81.8M
Q1 25
$171.2M
$23.1M
Q4 24
$141.3M
$-72.4M
Q3 24
$202.9M
$80.7M
Q2 24
$126.2M
$82.7M
Free Cash Flow
CLVT
CLVT
SPB
SPB
Q1 26
$78.9M
Q4 25
$89.2M
$59.3M
Q3 25
$115.5M
$157.9M
Q2 25
$50.3M
$71.8M
Q1 25
$110.3M
$13.9M
Q4 24
$59.1M
$-78.3M
Q3 24
$126.3M
$67.7M
Q2 24
$60.3M
$72.6M
FCF Margin
CLVT
CLVT
SPB
SPB
Q1 26
13.5%
Q4 25
14.5%
8.8%
Q3 25
18.5%
21.5%
Q2 25
8.1%
10.3%
Q1 25
18.6%
2.1%
Q4 24
8.9%
-11.2%
Q3 24
20.3%
8.7%
Q2 24
9.3%
9.3%
Capex Intensity
CLVT
CLVT
SPB
SPB
Q1 26
9.5%
Q4 25
11.5%
1.2%
Q3 25
10.5%
1.8%
Q2 25
10.6%
1.4%
Q1 25
10.3%
1.4%
Q4 24
12.4%
0.8%
Q3 24
12.3%
1.7%
Q2 24
10.1%
1.3%
Cash Conversion
CLVT
CLVT
SPB
SPB
Q1 26
Q4 25
51.58×
2.37×
Q3 25
3.08×
Q2 25
4.11×
Q1 25
25.67×
Q4 24
-3.08×
Q3 24
2.83×
Q2 24
13.56×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLVT
CLVT

Subscription$397.5M68%
Re-occurring$108.6M19%
Transactional$79.4M14%

SPB
SPB

HPC Segment$321.5M47%
Global Pet Supplies$168.7M25%
Home And Personal Care$109.8M16%
HG Segment$73.9M11%

Related Comparisons